Bill Ackman may have different goals Valeant Pharmaceuticals in bidding for Allergan, and that's just the start of the questions surrounding the unsual joint bid.
Companies seem to be seeing more opportunities to invest capital profitably, based on the latest quarterly report on corporate cash flow by the Financial Analysis Lab of the Georgia Institute of Technology
Senior mangement and boards need to be more aware of social media, Stanford Business School professor urges.
Companies with net operating losses may jeopardize their ability to use them when they structure deals as earn-outs, a prominent tax lawyer warns.
A new study finds that 20 percent of finance chiefs exploit gaps in accounting to misrepresent their companies' earnings, and their companies do so an average of ten percent of the time.
Corporate attorneys may be tempted to serve as whistleblowers, thanks to the Dodd-Frank Act and recent SEC rules.
Wtih negative guidance the second-highest on record for companies in the S&P 500, the perennial question of whether to provide guidance at all presents itself. Audit committees should be sure to get involved in the analysis, urges PwC.
Golden parachutes aren't what they once were, despite some recent high-profile exceptions at Time Warner Cable and Symantec.
If CFOs needed any further evidence that cybersecurity has taken its place among top risk management concerns, the Securities and Exchange Commission offered proof Wednesday. One conclusion reached? This is a problem to be managed, not solved.
To borrow or not to borrow? That depends on a host of considerations that only tangentially have to do with changes in the Federal Reserve's monetary policy. And weighing them properly may require people and technology that companies no longer have in place.